EXO Biologics

Liège, Belgium

EXO Biologics is a biotech company developing biopharmaceuticals using extracellular vesicles.

$16.0M raised

Apr 2024

Series A

Biopharma Biotechnology Life Science

Top Investors

Meusinvest (Noshaq)Walloon

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about EXO Biologics

How much funding has EXO Biologics raised?

EXO Biologics has raised $16.0M in total funding. The most recent round was Series A. The last funding was announced in April 2024.

Who are EXO Biologics's investors?

EXO Biologics's investors include Meusinvest (Noshaq), Walloon.

Where is EXO Biologics headquartered?

EXO Biologics is headquartered in Liège, Belgium.

What does EXO Biologics do?

EXO Biologics is a biotech company developing biopharmaceuticals using extracellular vesicles.

What stage is EXO Biologics at?

EXO Biologics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 24, 2024.

MLA

"EXO Biologics — Funding & Investors." VCBacked, April 24, 2024, https://www.vcbacked.co/company/exo-biologics. Accessed July 4, 2026.

APA

VCBacked. (2024). EXO Biologics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/exo-biologics

Wikipedia (cite web)

{{cite web |title=EXO Biologics — Funding & Investors |url=https://www.vcbacked.co/company/exo-biologics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 24, 2024.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.